SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-003042
Filing Date
2020-03-20
Accepted
2020-03-20 08:00:27
Documents
10
Period of Report
2020-03-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_031920.htm 8-K 28784
2 PRESENTATION ex99-1.htm EX-99.1 15577
3 GRAPHIC ex99-01_img001.jpg GRAPHIC 80398
4 GRAPHIC ex99-01_img002.jpg GRAPHIC 278544
5 GRAPHIC ex99-01_img003.jpg GRAPHIC 120227
6 GRAPHIC ex99-01_img004.jpg GRAPHIC 235929
7 GRAPHIC ex99-01_img005.jpg GRAPHIC 210983
8 GRAPHIC ex99-01_img006.jpg GRAPHIC 206438
9 GRAPHIC ex99-01_img007.jpg GRAPHIC 138971
10 GRAPHIC ex99-01_img008.jpg GRAPHIC 55212
  Complete submission text file 0001387131-20-003042.txt   1873806
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20730289
SIC: 2834 Pharmaceutical Preparations